arrow
R

Rino Rappuoli

fondazione toscana life sciences
H指数:143
被引数:7.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Innovative roadmaps for sustainable antimicrobial resistance interventions

创新的道路图用于可持续的抗菌素耐药性干预措施

2026-10-140
PRE
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153

抗原非依赖性鉴定靶向OPG153的痘病毒广谱中和抗体

2025-12-100
PRE
Invasive meningococcal disease in adolescents in Europe and select geographies: Disease burden, unmet medical need, and optimizing prevention

欧洲及特定地区青少年侵袭性脑膜炎球菌疾病:疾病负担、未满足的医疗需求及预防优化

2025-10-230
OAAI
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae

单克隆抗体可抵抗泛耐药肺炎克雷伯菌

Nature
IF48.5
2025-10-010
PRE
Microbes without borders: uniting societies for climate action

微生物无国界:团结社会共同应对气候变化

2025-10-010
OAAI
Microbes without borders: uniting societies for climate action

微生物无国界:联合社会应对气候变化

MBIO
IF4.7
2025-09-010
PRE
Microbial solutions for climate change require global partnership

微生物解决方案应对气候变化需要全球合作

MBIO
IF4.7
2025-05-140
OA
Microbes can capture carbon and degrade plastic - why aren't we using them?

微生物可以捕获碳并降解塑料——我们为什么不使用它们?

NATURE
IF48.5
2025-03-250
PRE
Microbes without borders: uniting societies for climate action

微生物无国界:联合社会共同应对气候变化

2025-01-010
OAAI
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses
2024-09-011
OAAI
Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion

奈瑟菌粘附素A (NadA) 以高亲和力结合人类Siglec-5和Siglec-14并促进细菌粘附/侵袭

MBIO
IF4.7
2024-08-140
OAAI